These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 24426781

  • 1. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
    Punekar YS, Shukla A, Müllerova H.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS, Landis SH, Wurst K, Le H.
    Respir Res; 2015 Nov 16; 16():141. PubMed ID: 26572740
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR, Zhou S, Shaikh A, Willey VJ.
    J Manag Care Spec Pharm; 2021 May 16; 27(5):625-637. PubMed ID: 33779246
    [Abstract] [Full Text] [Related]

  • 8. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K, Targowski T, From S.
    Pol Merkur Lekarski; 2009 Mar 16; 26(153):208-14. PubMed ID: 19388534
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M, Lambrelli D, MacLachlan S, Khalid JM.
    Int J Chron Obstruct Pulmon Dis; 2015 Mar 16; 10():925-37. PubMed ID: 25999708
    [Abstract] [Full Text] [Related]

  • 10. The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.
    Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R, Ibáñez-Nolla J.
    Lung; 2014 Aug 16; 192(4):505-18. PubMed ID: 24816902
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
    Khoudigian-Sinani S, Kowal S, Suggett JA, Coppolo DP.
    Int J Chron Obstruct Pulmon Dis; 2017 Aug 16; 12():3065-3073. PubMed ID: 29089755
    [Abstract] [Full Text] [Related]

  • 13. [Use of resources and associated costs of chronic obstructive pulmonary disease exacerbations: A population based retrospective study].
    Sicras A, Huerta A, Navarro R, Ibañez J.
    Semergen; 2014 Aug 16; 40(4):189-97. PubMed ID: 24485969
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population.
    Sethi S, Make BJ, Robinson SB, Kumar S, Pollack M, Moretz C, Dreyfus J, Xi A, Powell D, Feigler N.
    Int J Chron Obstruct Pulmon Dis; 2022 Aug 16; 17():593-608. PubMed ID: 35342290
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K, Sun SX, Ellis JJ, Howe A, Amin A.
    Int J Chron Obstruct Pulmon Dis; 2015 Aug 16; 10():565-76. PubMed ID: 25834417
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.